M&A Deal Summary

Globus Medical Acquires NuVasive

On April 27, 2023, Globus Medical acquired medical products company NuVasive

Acquisition Highlights
  • This is Globus Medical’s 6th transaction in the Medical Products sector.
  • This is Globus Medical’s 8th transaction in the United States.
  • This is Globus Medical’s 2nd transaction in California.

M&A Deal Summary
Date 2023-04-27
Target NuVasive
Sector Medical Products
Buyer(s) Globus Medical
Deal Type Merger

Target

NuVasive

San Diego, California, United States
Entrance to NuVasive's corporate headquarters in San Diego, California.
Entrance to NuVasive's corporate headquarters in San Diego, California.
NuVasive is a medical device company focused on the design, development, and marketing of products for the surgical treatment of spine disorders. NuVasive was formed in 1997 and is based in San Diego, California.

Search 200,500 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Buyer(S) 1

Buyer

Globus Medical

Audubon, Pennsylvania, United States
Category Company
Founded 2003
Sector Medical Products
Employees5,000
Revenue 1.6B USD (2023)
DESCRIPTION

Globus Medical is a musculoskeletal implant manufacturer and is driving significant technological advancements across a complete suite of spinal products. Globus Medical was founded in 2003 and is based in Audubon, Pennsylvania.

DEAL STATS #
Overall 9 of 9
Sector (Medical Products) 6 of 6
Type (Merger) 1 of 1
State (California) 2 of 2
Country (United States) 8 of 8
Year (2023) 1 of 1
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2020-10-21 Synoste Oy

Espoo, Finland

Synoste develops a high-tech implant for a minimally invasive treatment of leg length discrepancy, that can lead to chronic back pain and osteoarthritis in the long term. The bone of the shorter leg is lengthened in a gentle way over a period of several months. The Evonik material used in the implant is a high-performance polymer called polyetheretherketone, or PEEK. The material is biocompatible - not harmful or toxic to living tissue and has excellent mechanical properties. For the patient the implant represents easier treatment with less pain and lower risk compared to previously established methods. Synoste was formed in 2012 and is based in Espoo, Finland.

Buy -
Mergr

Product

Company

Legal